Clinical Trials Browser

Phase 2 × Coronavirus Infections × Clear all

COVID-19, Coronavirus Infections, Hematologic Neoplasms

NCT04447235 2022-08-09

TITAN

Phase 2 Terminated

77 enrolled

COVID-19, Neoplasms, Coronavirus Infections

NCT03944447 2022-06-02

OMNI-Can

Phase 2 Unknown

200,000 enrolled

Classical hematology

Chronic Traumatic Encephalopathy, Brain Injuries, Traumatic, COVID-19, Acquired Immunodeficiency Syndrome, Amyotrophic Lateral Sclerosis, Anemia, Sickle Cell, Anxiety Disorders, Autistic Disorder, Bipolar Disorder, Colitis, Ulcerative, Crohn Disease, Depression, Epilepsy, Fibromyalgia, Tourette Syndrome, Glaucoma, Hepatitis C, Sleep Initiation and Maintenance Disorders, Multiple Sclerosis, Opioid-Related Disorders, Neoplasms, Parkinson Disease, Seizures, Stress Disorders, Post-Traumatic, Inflammatory Bowel Diseases, Coronavirus Infections, Severe Acute Respiratory Syndrome, Chronic Pain

Clinical Trials

Anti-Interleukin-8 (Anti-IL-8) for Patients With COVID-19

TITAN

OMNI-Can